Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Preoperative injection of bevacizumab prior to vitreoretinal surgery in diabetic tractional retinal detachment

Trial Profile

Preoperative injection of bevacizumab prior to vitreoretinal surgery in diabetic tractional retinal detachment

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2018 Status changed from recruiting to completed.
    • 04 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top